The ACCME has long supported the role of accredited CME as a strategic partner in public health and safety initiatives. Through its interactions with government, other regulatory bodies in the healthcare field, accredited providers, and other stakeholders, the ACCME identifies and supports opportunities for accredited CME to support public health initiatives.
Resources
CME In Support of REMS: Updates and resources for accredited CME providers that choose to design education to fulfill the REMS goals.
Addressing Public Health Initiatives: A series of video interviews with CME and healthcare leaders about how CME can address public health initiatives.
Accredited CE and the FDA Risk Evaluation and Mitigation Strategy (REMS) for Opioid Analgesics: Murray Kopelow, MD, ACCME President and CEO, describes the role of accredited continuing health care education in supporting this important public health initiative.
How CME Can Address the Prescription Drug Abuse Epidemic: In a three-part video interview, David K. Mineta, Deputy Director of Demand Reduction, Office of National Drug Control Policy, provides a brief overview of the prescription drug abuse problem and describes specific approaches that accredited CME providers can incorporate in their activities to support proper prescribing and effective referral to treatment.
Highlights
Integrating Genomics into Accredited CME, September 26, 2013
Government Representatives Address ACCME Public Health Imperatives Forum, March 21, 2013
FDA Releases REMS for Extended-Release/Long-Acting Opioids, August 28, 2012